priority voucher program

https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program FDA Approves First New Molecular Entity Under National Priority Voucher Program | FDA The U.S. Food and Drug Administration today approved Foundayo (orforglipron) marking the fifth approval under the Commissioner's National Priority Voucher... fda approves first national priority voucher new molecular entity program https://www.biospace.com/fda/rare-disease-biotechs-stand-to-lose-4b-if-priority-voucher-program-not-reinstated-report Rare Disease Biotechs Stand To Lose $4B if Priority Voucher Program Not Reinstated: Report -... Jan 26, 2026 - Some 200 rare disease therapies are at risk of losing eligibility for a pediatric priority review voucher, a recent analysis by the Rare Disease Company... priority voucher program rare disease biotechs stand lose https://www.biospace.com/fda/9-months-in-fdas-new-priority-voucher-program-still-clouded-with-uncertainty 9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty - BioSpace Mar 23, 2026 - The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic representative Jake Auchincloss said... priority voucher program 9 months new still clouded

Robuta